UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000002739
Receipt number R000003331
Scientific Title The pharmacokinetic study of drug interaction between metformin and pyrimethamine from microdose to clinical dose in adult healthy volunteers
Date of disclosure of the study information 2009/11/13
Last modified on 2010/05/06 13:32:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The pharmacokinetic study of drug interaction between metformin and pyrimethamine from microdose to clinical dose in adult healthy volunteers

Acronym

The drug interaction study between metformin and pyrimethamine

Scientific Title

The pharmacokinetic study of drug interaction between metformin and pyrimethamine from microdose to clinical dose in adult healthy volunteers

Scientific Title:Acronym

The drug interaction study between metformin and pyrimethamine

Region

Japan


Condition

Condition

healthy male subjects

Classification by specialty

Not applicable

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To evaluate the pharmacokinetics in vivo in healthy volunteers of metformin in a single dose from microdose to clinical dose with or without pyrimethamine

Basic objectives2

Pharmacokinetics

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pharmacokinetic parameters in plasma

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

four terms
Phase 1(washout 1week)-phase2(washout 3weeks)-phase3(washout 1week)-phase4
phase1 metformin(MD)
Phase2 metformin(MD) and pyrimethamine
Phase3 metformin(CD)
Phase4 metformin(CD) and pyrimethamine
single dose in each term

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

35 years-old >

Gender

Male

Key inclusion criteria

1) Ability to understand and willing to sign the informed consent.
2) Japanese healthy male subjects age 20 to 35 years of age
3) Body Mass Index (BMI):18.5~28.5
4) good health as determined by physical examination, vital signs and laboratory tests.

Key exclusion criteria

1) Any medical condition that requires medical attention
2) Impairments of liver or kidney functions
3) Dysemia and history of this disease
4) Cardiac disease or respiratory disease and history of them
5) Any hypersensitivity to pyrimethamine or metformin
6) Use of medicine or health product including Saint John's wort 2 weeks before pre-dose.
7) Intake of fruit food and drink including grapefruit juice, orange juice or apple juice from 7 days before pre-dose.
8) Participation to any other clinical research in the past 3 months.
9)Donating over 200 ml of blood in the past 1 month or over 400ml of blood in the past 3 months.
10) Positive tests of serological reaction for syphilis, HIV antigen and antibody, HBs antigen or HCV antibody.
11) Any allergy to drug and food
12) history of drug or alcohol abuse
13) Any condition that, in the opinion of the investigator, would make the patient unsuitable for the study

Target sample size

8


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Yuji Kumagai

Organization

Kitasato University East Hospital

Division name

Clinical trial Center

Zip code


Address

2-1-1, Asamizodai, Sagamihara, Kanagawa, 228-8520

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name

Organization

Kitasato University East Hospital

Division name

Clinical trial Center

Zip code


Address

2-1-1, Asamizodai, Sagamihara, Kanagawa, 228-8520

TEL


Homepage URL


Email



Sponsor or person

Institute

Clinical trial Center,Kitasato University East Hospital

Institute

Department

Personal name



Funding Source

Organization

APDD, Association for Promoting Drug Development

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2009 Year 11 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2009 Year 10 Month 30 Day

Date of IRB


Anticipated trial start date

2009 Year 12 Month 01 Day

Last follow-up date

2010 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2009 Year 11 Month 10 Day

Last modified on

2010 Year 05 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000003331


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name